Bone and soft tissue sarcoma sarcoma
Conditions
Interventions
Multi-ion radiotherapy
Sponsors
Imai Reiko
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Histologically diagnosed high-grade bone and soft tissue sarcomas, excluding chordoma. 2. Planning target volume is more than 400cm3. 3. Measurable target lesions in treatment-naive or recurrent cases 4. No extensive lymph node metastasis or distant metastasis. 5. PS (Performance Status) is 0 - 2. 6. Expected survival of 6 months or more. 7. Patients who understand the study and have given informed written consent to participate in this study. If the subject is a minor, the consent of a surrogate must be obtained.
Exclusion criteria
Exclusion criteria: 1.Patients with serious complications. 2.Patients with active double cancer. 3.Patients who have a history of radiation therapy to the target. 4.Patients with active infection in the irradiated area. 5.Patients who are judged by the physicians in charge to be inappropriate for this study for medical or other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Early adverse events in normal tissue | — |
Secondary
| Measure | Time frame |
|---|---|
| tumor response rate, late adverse events in normal tissue | — |
Contacts
Public ContactReiko Imai
National Institutes for Quantum Science and Technology
Outcome results
None listed